MERCK - INDUSTRY SUPPORTED SYMPOSIUM

Print
Sanofi Genzyme
INDUSTRY SPONSORED SYMPOSIUM
Supported by Merck
Friday, March 23, 2018
13:20-14:20

Selective immune reconstitution therapy: a new era in the clinical management of MS

Topic
Time
Speaker
Welcome and introduction
13:20 – 13:25
Chair: Prof Krzystof Selmaj
Rationale for targeting T and B cells in patients with MS
13:25 – 13:40
Prof Mark Freedman
Implications of T and B cell depletion: efficacy and safety of immune reconstitution therapies
13:40 – 13:55
Prof Krzystof Selmaj 
Integrating immune reconstitution therapies into clinical practice
13:55 – 14:10
Prof Thomas Müller
Q&A and meeting close
14:10 – 14:20
Chair: Prof Krzystof Selmaj